Kotaro Hattori
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Increased Cerebrospinal Fluid Lactate Levels in Schizophrenia and Major Depressive Disorder: NCNP Biobank Study in Japan.
Journal: Neuropsychopharmacology reports
Published: November 10, 2025
AMPA receptor palmitoylation restrains ictogenesis in the epileptogenic lesion of patients with hippocampal sclerosis.
Journal: Biochemical pharmacology
Published: August 15, 2025
Chronic reduction of synaptic proteins in the epileptogenic lesion of patients with hippocampal sclerosis.
Journal: Frontiers in molecular neuroscience
Published: May 27, 2025
Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.
Journal: Molecular psychiatry
Published: May 02, 2025
Cerebrospinal fluid neuromarker levels in patients with schizophrenia: a multiplex immunoassay study with a large sample.
Journal: Psychiatry and clinical neurosciences
Published: March 22, 2025
Mediators of the Association Between Severity of Noncommunicable Diseases and Subjective Health-Related Quality of Life.
Journal: Neuropsychopharmacology reports
Published: February 13, 2025
High Rates of Abnormal Glucose Metabolism Detected by 75 g Oral Glucose Tolerance Test in Major Psychiatric Patients with Normal HbA1c and Fasting Glucose Levels.
Journal: Nutrients
Published: December 31, 2024
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 26, 2024
Plasma microRNAs Associate Positive, Negative, and Cognitive Symptoms with Inflammation in Schizophrenia.
Journal: International journal of molecular sciences
Published: November 25, 2024
Serum lipid and plasma fatty acid profiles in PTSD patients and healthy individuals: Associations with symptoms, cognitive function, and inflammatory markers.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 19, 2024
Genome-wide DNA methylation profiling of blood samples from patients with major depressive disorder: correlation with symptom heterogeneity.
Journal: Journal of psychiatry & neuroscience : JPN
Published: September 27, 2024
Last Updated: 09/26/2026